References
- Hunter KD, Parkinson EK, Harrison PR. Profiling early head and neck cancer. Nat.Rev Cancer 2005; 5: 127–35
- Nigg EA. Centrosome aberrations: cause or consequence of cancer progression?. Nat.Rev Cancer 2002; 2: 815–25
- Yamamoto Y, Matsuyama H, Kawauchi S, Furuya T, Liu XP, Ikemoto K, et al. Biological characteristics in bladder cancer depend on the type of genetic instability. Clin Cancer Res. 2006; 12: 2752–8
- Bockmuhl U, Petersen I. DNA ploidy and chromosomal alterations in head and neck squamous cell carcinoma. Virchows Arch. 2002; 441: 541–50
- Kayser G, Gerlach U, Walch A, Nitschke R, Haxelmans S, Kayser K, et al. Numerical and structural centrosome aberrations are an early and stable event in the adenoma-carcinoma sequence of colorectal carcinomas. Virchows Arch. 2005; 447: 61–5
- Pihan GA, Purohit A, Wallace J, Malhotra R, Liotta L, Doxsey SJ. Centrosome defects can account for cellular and genetic changes that characterize prostate cancer progression. Cancer Res. 2001; 61: 2212–9
- Yamamoto Y, Matsuyama H, Furuya T, Oga A, Yoshihiro S, Okuda M, et al. Centrosome hyperamplification predicts progression and tumor recurrence in bladder cancer. Clin Cancer Res. 2004; 10: 6449–55
- Gisselsson D, Jonson T, Yu C, Martins C, Mandahl N, Wiegant J, et al. Centrosomal abnormalities, multipolar mitoses, and chromosomal instability in head and neck tumours with dysfunctional telomeres. Br J Cancer 2002; 87: 202–7
- Reiter R, Gais P, Jutting U, Steuer-Vogt MK, Pickhard A, Bink K, et al. A. Aurora kinase a messenger RNA overexpression is correlated with tumor progression and shortened survival in head and neck squamous cell carcinoma. Clin Cancer Res. 2006; 12: 5136–41
- Sobin LH, Wittekind CH. TNM classification of malignant tumors. John and Sons Inc, New YorkUSA 1992
- Moebius C, Stein HJ, Feith M, Theisen J, Gais P, Juetting U, et al. The angiogenic switch in the progression from Barrett's metaplasie to esophageal adenocarcinoma. EJSO 2003; 29: 890–4
- Walch A, Bink K, Hutzler P, Bowering K, Letsiou I, Zitzelsberger H, et al. Sequential multilocus fluorescence in situ hybridization can detect complex patterns of increased gene dosage at the single cell level in tissue sections. Lab Invest. 2001; 81: 1457–9
- Reshmi SC, Saunders WS, Kudla DM, Ragin CR, Gollin SM. Chromosomal instability and marker chromosome evolution in oral squamous cell carcinoma. Genes Chromosomes Cancer 2004; 41: 38–46
- Pihan GA, Wallace J, Zhou Y, Doxsey SJ. Centrosome abnormalities and chromosome instability occur together in pre-invasive carcinomas. Cancer Res. 2003; 63: 1398–404
- Meraldi P, Nigg EA. The centrosome cycle. FEBS Lett. 2002; 521: 9–13
- Meraldi P, Honda R, Nigg EA. Aurora kinases link chromosome segregation and cell division to cancer susceptibility. Curr Opin Genet Dev. 2004; 14: 29–36
- Hoque A, Carter J, Xia W, Hung MC, Sahin AA, Sen S, et al. Loss of aurora A/STK15/BTAK overexpression correlates with transition of in situ to invasive ductal carcinoma of the breast. Cancer Epidemiol Biomarkers Prev. 2003; 12: 1518–22
- Li Y, Li F, Li-Ling J, Wang X, Xu Z, Sun K. STK15 gene overexpression, centrosomal amplification, and chromosomal instability in the absence of STK15 mutations in laryngeal carcinoma. Cancer Invest. 2005; 3: 660–4
- Marumoto T, Zhang D, Saya H. Aurora-A—a guardian of poles. Nat Rev Cancer 2005; 5: 42–50
- Miyoshi Y, Iwao K, Egawa C, Noguchi S. Association of centrosomal kinase STK15/BTAK mRNA expression with chromosomal instability in human breast cancers. Int J Cancer 2001; 92: 370–3